An intellectual property law leader and champion
Carol Pitzel Cruz serves as the managing partner of Knobbe Martens’ Seattle office and co-chair of its Hatch-Waxman Litigation practice, establishing herself as a leading intellectual property attorney with a focus on pharmaceutical litigation. She is a passionate advocate for equitable healthcare and champions the advancement of women’s representation in the field of intellectual property law.
In her role as head of the Seattle office, Pitzel Cruz fosters a collaborative and inclusive environment that not only drives office growth but also attracts top-tier legal talent. Her expertise in high-stakes Abbreviated New Drug Application (ANDA) litigation has resulted in significant victories for generic drug manufacturers, thereby enhancing access to essential healthcare solutions. Notably, she recently achieved a favorable ruling for Padagis Pharmaceuticals concerning the glaucoma medication Simbrinza®, showcasing her adeptness in navigating the complexities of patent litigation.
Currently, Pitzel Cruz represents Lupin in ongoing litigation against Astellas Pharma regarding mirabegron, where her efforts have led to a pivotal ruling that enables Lupin to advance its generic product.
Renowned for her diplomatic and diligent approach, Pitzel Cruz is a respected figure in intellectual property litigation, consistently positioning her clients for strategic success. Her extensive background in Seattle’s biotechnology sector enriches her understanding of pharmaceutical patent issues, facilitating effective communication with industry experts and the formulation of pragmatic legal strategies. Clients value her unique combination of scientific acumen and legal expertise, often relying on her guidance to navigate intricate IP challenges. As a strategic leader and mentor, she is committed to fostering excellence within her teams, ensuring they are well-equipped to meet the demands of a rapidly evolving legal landscape.
